Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry on WATCHMAN Outcomes in Real-Life Utilization

NCT01972282 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01972282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01972282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry on WATCHMAN Outcomes in Real-Life Utilization
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
October 28, 2013
Completion date
January 4, 2018
Enrollment
1,025 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

patients with atrial fibrillation at risk for thrombus formation, thromboembolism, stroke